Literature DB >> 8670335

Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.

A de Paulis1, I Marinò, A Ciccarelli, G de Crescenzo, M Concardi, L Verga, E Arbustini, G Marone.   

Abstract

OBJECTIVE: To examine the ultrastructure of human synovial mast cells in situ, to identify immunologic and nonimmunologic stimuli that activate these cells in vitro, and to quantify a number of preformed and de novo-synthesized mediators.
METHODS: We conducted an ultrastructural study of synovial mast cells in situ and performed immunoelectron microscopy localization of tryptase and chymase. Isolated synovial mast cells were analyzed biochemically, immunologically, and functionally in vitro and compared with cells from human lung, heart, and skin.
RESULTS: Ultrastructural study of synovial tissue revealed mast cells with homogeneously dense, scrolled, crystal, and mixed granules, and lipid bodies in the cytoplasm. A small percentage of mast cells showed evidence of degranulation. Immunoelectron microscopy demonstrated the subcellular localization of tryptase and chymase over granules of > 90% of the mast cells, which were of the MCTC subtype. Isolated synovial mast cells released histamine in response to immunologic (anti-IgE and anti-Fc epsilon receptor I [anti-Fc epsilon RI]) and nonimmunologic (substance P, recombinant human stem cell factor, and 48/80) stimuli, but did not respond to recombinant human C5a in vitro. Synovial mast cells differed from those isolated from other human tissues, in a variety of immunologic and biochemical features. There was a linear correlation between the percentage of histamine secretion and tryptase release (r = 0.79, P < 0.001) induced by cross-linking of Fc epsilon RI. Cross-linking of IgE with anti-IgE on synovial mast cells induced de novo synthesis of prostaglandin D2 (mean +/- SEM 87.5 +/- 4.9 ng/10(6) cells) and of leukotriene C4 (57.6 +/- 17.8 ng/10(6) cells).
CONCLUSION: Mast cells ultrastructurally characterized in situ in synovial tissue were seen to differ from mast cells previously isolated from other human tissues. This raises the possibility that the local microenviroment influences their phenotype. Isolation of mast cells from human synovia can be useful for studying their role and their mediators in patients with arthritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670335     DOI: 10.1002/art.1780390723

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats.

Authors:  Jason J McDougall; Ali Kursat Barin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 2.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

Authors:  P Romagnani; A De Paulis; C Beltrame; F Annunziato; V Dente; E Maggi; S Romagnani; G Marone
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.

Authors:  Remo Poto; Vincenzo Patella; Gjada Criscuolo; Gianni Marone; Enrico Coscioni; Gilda Varricchi
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

5.  Age alters the ability of substance P to sensitize joint nociceptors in guinea pigs.

Authors:  Jason J McDougall; Niklas Schuelert
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.

Authors:  I Gotis-Graham; M D Smith; A Parker; H P McNeil
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

7.  Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.

Authors:  Nadia Zayed; Hassan Afif; Nadir Chabane; Leandra Mfuna-Endam; Mohamed Benderdour; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Rajender K Motiani; Mohamed Trebak; Nicolas Duval; Hassan Fahmi
Journal:  Arthritis Rheum       Date:  2008-11

8.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

9.  Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.

Authors:  Shunji Nakano; Takuya Mishiro; Shigeyuki Takahara; Hiromichi Yokoi; Daisuke Hamada; Kiminori Yukata; Yoichiro Takata; Tomohiro Goto; Hiroshi Egawa; Susumu Yasuoka; Harumi Furouchi; Katsuya Hirasaka; Takeshi Nikawa; Natsuo Yasui
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 3.650

10.  Prostaglandins and rheumatoid arthritis.

Authors:  Mohammad Javad Fattahi; Abbas Mirshafiey
Journal:  Arthritis       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.